Lan Deng
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 25
- Acute Myeloid Leukemia Research 12
- Hematopoietic Stem Cell Transplantation 10
- Oncology 10
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 2
- Viral-associated cancers and disorders 2
- Co-authors
- Le Zhao (6 shared papers)Zhigang Lu (5 shared papers)Qifa Liu (11 shared papers)Wei Xu (4 shared papers)Zhenping Zhu (5 shared papers)Na Xu (6 shared papers)Fen Huang (6 shared papers)Li Xuan (6 shared papers)
- Journals
- Bone Marrow Transplantation (3 papers)Acta Pharmacologica Sinica (2 papers)Journal of Hematology & Oncology (2 papers)mAbs (2 papers)Journal of Internal Medicine (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lan Deng
55 papers receiving 1.1k citations
Lan Deng's Hit Papers
Peers
Comparison fields: 5 of 62
- Hematology 636
- Oncology 197
- Genetics 41
- Drug Discovery 1
- Medical Terminology 1
Countries citing papers authored by Lan Deng
This map shows the geographic impact of Lan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Deng more than expected).
Fields of papers citing papers by Lan Deng
This network shows the impact of papers produced by Lan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Deng. The network helps show where Lan Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial Hit paper breakdown → | 2020 | 258 |
| 2 | 2022 | 66 | |
| 3 | 2023 | 57 | |
| 4 | 2018 | 52 | |
| 5 | 2023 | 51 | |
| 6 | 2017 | 48 | |
| 7 | 2020 | 48 | |
| 8 | 2021 | 45 | |
| 9 | 2020 | 44 | |
| 10 | 2022 | 37 | |
| 11 | 2022 | 33 | |
| 12 | 2020 | 30 | |
| 13 | 2017 | 27 | |
| 14 | 2019 | 27 | |
| 15 | 2020 | 21 | |
| 16 | 2023 | 20 | |
| 17 | 2019 | 19 | |
| 18 | 2021 | 19 | |
| 19 | 2021 | 18 | |
| 20 | 2015 | 16 |
About Lan Deng
Lan Deng is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Public Health, Environmental and Occupational Health and Immunology, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hepatitis B Virus Studies (2 papers), CAR-T cell therapy research (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (636 citations), Oncology (197 citations), Genetics (41 citations), Drug Discovery (1 citation) and Medical Terminology (1 citation). Lan Deng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Le Zhao, Zhigang Lu, Qifa Liu, Wei Xu, Zhenping Zhu, Na Xu, Fen Huang, Li Xuan, Kuo‐Fu Tseng and Bingyi Wu. Their work appears in journals such as Bone Marrow Transplantation, Acta Pharmacologica Sinica, Journal of Hematology & Oncology, mAbs and Journal of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.